BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22037780)

  • 1. A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance.
    Meads C; Ahmed I; Riley RD
    Breast Cancer Res Treat; 2012 Apr; 132(2):365-77. PubMed ID: 22037780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of non-clinical risk models to aid prevention of breast cancer.
    Al-Ajmi K; Lophatananon A; Yuille M; Ollier W; Muir KR
    Cancer Causes Control; 2018 Oct; 29(10):967-986. PubMed ID: 30178398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.
    Wang X; Huang Y; Li L; Dai H; Song F; Chen K
    Breast Cancer Res; 2018 Mar; 20(1):18. PubMed ID: 29534738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.
    Rockhill B; Spiegelman D; Byrne C; Hunter DJ; Colditz GA
    J Natl Cancer Inst; 2001 Mar; 93(5):358-66. PubMed ID: 11238697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Prediction Models for Cardiotoxicity of Chemotherapy Among Patients With Breast Cancer: A Systematic Review.
    Kaboré EG; Macdonald C; Kaboré A; Didier R; Arveux P; Meda N; Boutron-Ruault MC; Guenancia C
    JAMA Netw Open; 2023 Feb; 6(2):e230569. PubMed ID: 36821108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the quality of clinical prediction models in in vitro fertilisation.
    Ratna MB; Bhattacharya S; Abdulrahim B; McLernon DJ
    Hum Reprod; 2020 Jan; 35(1):100-116. PubMed ID: 31960915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.
    Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Zeleniuch-Jacquotte A; Liu M
    Breast Cancer Res; 2019 Mar; 21(1):42. PubMed ID: 30890167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.
    Archer R; Hock E; Hamilton J; Stevens J; Essat M; Poku E; Clowes M; Pandor A; Stevenson M
    Health Technol Assess; 2018 Nov; 22(66):1-294. PubMed ID: 30501821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk prediction models of breast cancer: a systematic review of model performances.
    Anothaisintawee T; Teerawattananon Y; Wiratkapun C; Kasamesup V; Thakkinstian A
    Breast Cancer Res Treat; 2012 May; 133(1):1-10. PubMed ID: 22076477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the contribution of lifestyle in breast cancer risk prediction: a systematic review of models applicable to Europe.
    Mertens E; Barrenechea-Pulache A; Sagastume D; Vasquez MS; Vandevijvere S; Peñalvo JL
    BMC Cancer; 2023 Jul; 23(1):687. PubMed ID: 37480028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of changing breast cancer incidence rates on the calibration of the Gail model.
    Schonfeld SJ; Pee D; Greenlee RT; Hartge P; Lacey JV; Park Y; Schatzkin A; Visvanathan K; Pfeiffer RM
    J Clin Oncol; 2010 May; 28(14):2411-7. PubMed ID: 20368565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective breast cancer risk prediction model for women undergoing screening mammography.
    Barlow WE; White E; Ballard-Barbash R; Vacek PM; Titus-Ernstoff L; Carney PA; Tice JA; Buist DS; Geller BM; Rosenberg R; Yankaskas BC; Kerlikowske K
    J Natl Cancer Inst; 2006 Sep; 98(17):1204-14. PubMed ID: 16954473
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.